×
Pokémon Violet and Scarlet’s Switch 2 update is as good as it looks

Pokémon Violet and Scarlet’s Switch 2 update is as good as it looks

I recently did something sort of unusual: I went to a preview event for a game that’s been out for almost three years.

I’ve played around 400 hours of Pokémon Scarlet, according to my Nintendo Switch, since it was released in late 2022. It’s safe to say I know the game pretty well. And yet, when I was invited to preview Pokémon Scarlet and Violet on the Nintendo Switch 2 ahead of the new console’s launch, I gladly took the opportunity to see three-year-old games I already own. I wanted to find out just how much they’d improved.

I have a high jank tolerance with games — it builds character — but I’m well aware of Scarlet and Violet’s shortcomings on the original Switch. There’s lag. The frame rate is… inconsistent. There are online connectivity issues. For a lot of people, performance problems overshadowed what was otherwise a great new generation of Pokémon games. With the release of the Nintendo Switch 2, and the accompanying free performance update for Scarlet and Violet, that might finally change.

Starting up the demo of Pokémon Scarlet on the Switch 2 at The Pokémon Company International’s office in Bellevue, Washington, I knew immediately where I wanted to go first: Casseroya Lake, sometimes called “Lag Lake,” where the games’ graphical issues are most apparent. On the original Switch, the game really chugs when you’re on the lake; the frame rate takes a dive, and it struggles to render more than a handful of pokémon in your immediate vicinity. Exploring the liveliest open areas and encountering the pokémon that populate them is one of Scarlet and Violet’s biggest strengths, but on the Switch, Casseroya Lake is dull and empty at best and impossible to navigate at worst.

Playing on the Switch 2, however, Casseroya Lake ran beautifully. There were far more pokémon in view (and I was immediately accosted by a torpedo-like Veluza, same as it ever was), and the lag and stuttering I’d come to expect were nonexistent. I battled that Veluza with no problems. I stumbled upon a Slowpoke outbreak and sent out my Clodsire to auto-battle them — no lag. I found a wild Tera Pokémon and watched the Tera animation play out, looking sharper than I’d ever seen it. (I was playing in docked mode at a station set up by TPCi, so maybe that last one could be credited to the TV. But still.)

It was the same case everywhere I went during my 30-minute demo: a stable and smooth frame rate, significantly faster load times, and far more pokémon populating the world. The Switch 2 update is not a complete overhaul of the graphics themselves — the grass textures looked just as unremarkable as always to my eye, for example — but it does seem to eliminate the performance issues that have dragged Scarlet and Violet down for nearly three years. It’s a noticeable improvement in the world, in battle, in Tera raids, and even in menus.

Is it praiseworthy for a game to simply run well? Maybe not. I don’t pretend to know how games are made on a technical level, or really any level, but I know they’re not easy to make. And I had enough fun with Pokémon Scarlet to play for 400 hours without the performance issues bothering me much. But it did feel bittersweet, briefly, to think how much more these games could have shone if they’d run well in the first place.

Then, in the last five minutes of my demo, as I waded in a different body of water to confirm that it too ran smoothly, I saw it: among the pods of Buizel dotting the shore, a shiny.

A good portion of my 400 hours in Scarlet were spent shiny hunting, because even though the alternate-color versions of pokémon are not quite as hard to find as they were in previous games, I get excited every time I see one, without fail. It’s the perfect encapsulation of the kind of joy Scarlet and Violet have to offer: exploring a lively area and finding something special. I caught the shiny Buizel despite knowing that it wasn’t my save file and not mine to keep.

The Switch 2 update is arguably arriving a bit late for my Scarlet save file, depending on how many hours you think are reasonable to spend playing this game. But I also own Violet, and I have played about two hours of that version total. Looking at the shiny Buizel I didn’t get to keep, I realized I was really excited to have a reason to play Violet finally — to rediscover what I liked most about these games, in a state that does them justice.

Source link
#Pokémon #Violet #Scarlets #Switch #update #good

Samsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech">Samsung’s new foldable display is harder to crease and damageSamsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech

Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech">Samsung’s new foldable display is harder to crease and damage

Samsung has unveiled a new flexible display technology for foldable phones that’s designed to be slimmer, more durable, and less prone to creasing. The Flex Titanium tech is the culmination of everything that the company has learned over seven generations of foldables, according to Samsung, and will debut with the upcoming Galaxy Z Fold 8 and Galaxy Z Fold 8 Ultra. And since Samsung Display is a long-time Apple supplier, this improved display might even appear in the rumored iPhone foldable expected later this year.

As its name suggests, the Flex Titanium display uses a combination of two titanium-based components to improve strength, flexibility, and slimness. A titanium-alloy film provides structural support from underneath the OLED panel, providing “20 times greater mechanical stiffness” compared to polymer film, and measures about one-third the thickness of an average human hair.

A titanium plate located under the film enables tighter bonding with the display module, improving stability when unfolded while “retaining the flexibility needed to accommodate repeated folding,” according to Samsung. This new display tech will also consume less power and produce “ultra-vivid” display visual resolution.

“Together, these advancements enable a strong foldable display that maximizes content immersion on a seamless screen and reduces crease visibility — all while keeping it slim,” Samsung said in its announcement. “By balancing strength, flexibility and structural stability, Samsung continues to set the bar for foldable displays.”

Further details about the display will be available at Samsung’s Galaxy Unpacked event on July 22nd where Samsung’s latest foldables are expected to be showcased.

#Samsungs #foldable #display #harder #crease #damageFoldable Phones,Mobile,News,Samsung,Tech
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI">OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at B | TechCrunch
Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about 0 million at a  billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.







Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised 0 million at a .8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a .1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI

Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI">OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B | TechCrunch

Miles Wang, an OpenAI researcher whose work includes using AI to accelerate scientific and biological discovery, is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery, according to four people with knowledge of his plans. Several other OpenAI researchers are expected to join the new company.  

Wang is in talks to raise about $200 million at a $2 billion valuation, two of the people said. Lightspeed is in discussions to lead the funding round, according to sources. Talks are ongoing, the deal may not be final and details could change.

Wang disputed the story’s funding figures and description of the company but did not specify the correct numbers or details. Lightspeed didn’t respond to a request for comment.

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences. Chai Discovery, a two-year-old startup developing AI models that can predict molecular interactions to identify new drugs, announced on Tuesday that it raised $400 million at a $3.8 billion valuation. (Co-founder Josh Meier also passed through OpenAI as a researcher.) Meanwhile, Google DeepMind spinout Isomorphic Labs, which also develops AI models for drug discovery, raised a $2.1 billion Series B in May.

Wang’s new startup may be working on AI models that will help find new uses for existing drugs and possibly those that previously failed in trials, a couple of sources told TechCrunch. Finding new uses for FDA-approved drugs can result in significantly faster time to revenue than developing new drugs from scratch, as these medicines have already been tested for safety.

Wang joined OpenAI in 2024 after dropping out from Harvard, where he was working on a bachelor’s degree in computer science. (In recent years, investors are once again comfortable betting on young founders who haven’t completed college.)

At OpenAI, he co-authored research papers, including evaluating how AI models can automate and accelerate scientific discovery.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

#OpenAI #researcher #Miles #Wang #talks #launch #drug #discovery #startup #valued #TechCrunchdrug discovery,lightspeed,OpenAI

Post Comment